CA89393/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	1
2002	2
2003	6
2004	5
2005	3
2006	11
2007	4
2008	19
2009	6
2010	17
2011	8
2012	6
2013	4
2014	2
2015	1
2017	1
2018	1
2024	0

1

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.

Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA. Punglia RS, et al. Breast Cancer Res Treat. 2018 Feb;167(3):751-759. doi: 10.1007/s10549-017-4553-5. Epub 2017 Oct 28. Breast Cancer Res Treat. 2018. PMID: 29079937

2

Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.

Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, Stockerl-Goldstein K, Neumayer L, Langbaum TS, Theriault RL, Hughes ME, Weeks JC, Karp JE. Wolff AC, et al. J Clin Oncol. 2015 Feb 1;33(4):340-8. doi: 10.1200/JCO.2013.54.6119. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534386 Free PMC article.

3

Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.

Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS. Greenberg CC, et al. Ann Surg Oncol. 2014 Nov;21(12):3766-73. doi: 10.1245/s10434-014-3802-7. Epub 2014 May 24. Ann Surg Oncol. 2014. PMID: 24859938 Free PMC article.

4

Nourseothricin N-acetyl transferase: a positive selection marker for mammalian cells.

Kochupurakkal BS, Iglehart JD. Kochupurakkal BS, et al. PLoS One. 2013 Jul 4;8(7):e68509. doi: 10.1371/journal.pone.0068509. Print 2013. PLoS One. 2013. PMID: 23861913 Free PMC article.

5

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Rath MG, Masciari S, Gelman R, Miron A, Miron P, Foley K, Richardson AL, Krop IE, Verselis SJ, Dillon DA, Garber JE. Rath MG, et al. Breast Cancer Res Treat. 2013 May;139(1):193-8. doi: 10.1007/s10549-012-2375-z. Epub 2013 Apr 12. Breast Cancer Res Treat. 2013. PMID: 23580068 Free PMC article.

6

Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.

Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC. Vandergrift JL, et al. J Natl Cancer Inst. 2013 Jan 16;105(2):104-12. doi: 10.1093/jnci/djs506. Epub 2012 Dec 21. J Natl Cancer Inst. 2013. PMID: 23264681 Free PMC article.

7

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.

Freedman RA, Hughes ME, Ottesen RA, Weeks JC, He Y, Wong YN, Theriault R, Keating NL. Freedman RA, et al. Cancer. 2013 Feb 15;119(4):839-46. doi: 10.1002/cncr.27831. Epub 2012 Sep 25. Cancer. 2013. PMID: 23011924 Free PMC article.

8

Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.

Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Arvold ND, et al. Cancer. 2012 Dec 15;118(24):6022-30. doi: 10.1002/cncr.27691. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674478 Free PMC article.

9

The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer.

Shearin AL, Hedan B, Cadieu E, Erich SA, Schmidt EV, Faden DL, Cullen J, Abadie J, Kwon EM, Gröne A, Devauchelle P, Rimbault M, Karyadi DM, Lynch M, Galibert F, Breen M, Rutteman GR, André C, Parker HG, Ostrander EA. Shearin AL, et al. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1019-27. doi: 10.1158/1055-9965.EPI-12-0190-T. Epub 2012 May 23. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22623710 Free PMC article.

10

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. Hassett MJ, et al. J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14. J Clin Oncol. 2012. PMID: 22585699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year